Mitsubishi UFJ Trust & Banking
PCRX icon

Mitsubishi UFJ Trust & Banking’s Pacira BioSciences PCRX Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Buy
18,656
+8,282
+80% +$196K ﹤0.01% 1077
2026
Q1 		$234K Hold
10,374
– – ﹤0.01% 1051
2025
Q4 		$268K Buy
+10,374
New +$247K ﹤0.01% 1036

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's PCRX Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking increased its Pacira BioSciences (PCRX) stake by 80% in Q2 2026, buying an estimated $196K and bringing the position to 18,656 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Mitsubishi UFJ Trust & Banking first reported a position in PCRX in Q4 2025 and has held it in 3 quarters since. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 18,656 shares of Pacira BioSciences worth $473K as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking bought 8,282 Pacira BioSciences shares in Q2 2026, an estimated $196K.
  • Pacira BioSciences made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1077 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Pacira BioSciences in Q4 2025 and has held it in 3 quarters since.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.